Financials
- Market Capitalization 4.23 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-41.64
売上高対価格比率
8.9
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1366 | DNTH Dianthus Therapeutics, Inc. - Common Stock | 82.37 USD | -0.07% | -6.86% | -23.98% | +138.34% | 4.61 B USD | ||
| 1420 | EWTX Edgewise Therapeutics, Inc. - Common Stock | 39.06 USD | -0.43% | -5.99% | -11.19% | +156.47% | 4.24 B USD | ||
| 1458 | TNGX Tango Therapeutics, Inc. - Common Stock | 23.81 USD | +5.49% | +2.81% | -0.71% | +228.41% | 4.01 B USD | ||
| 1476 | RLAY Relay Therapeutics, Inc. - Common Stock | 17.88 USD | +2.70% | -5.89% | -5.65% | +170.91% | 3.92 B USD |